The current findings identify TFAM as a context-dependent regulator of glioma cell phenotype, with its loss driving proliferative, ROS-prone states in GPM GBM cells but eliciting adaptive stress-resilient programs in MTC-type cells. The gene discussed is TFAM; the disease is glioblastoma.